Advanced Enzyme Technologies Limited Market Cap ($328.59 Million)
Market Cap & Net Worth: Advanced Enzyme Technologies Limited (ADVENZYMES)
Advanced Enzyme Technologies Limited market cap. Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) has a market capitalization of $328.59 Million (Rs30.38 Billion) as of November 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #14077 globally and #700 in its home market, demonstrating a 8.76% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Advanced Enzyme Technologies Limited's stock price Rs274.25 by its total outstanding shares 110788000 (110.79 Million). Also see cash efficiency ratio of Advanced Enzyme Technologies Limited for how efficiently the company converts equity into cash flow.
Advanced Enzyme Technologies Limited Market Cap History (2016–2026)
Advanced Enzyme Technologies Limited market cap history from 2016 to 2026. Data shows growth from $452.81 Million to $328.59 Million (1.97% CAGR). Check ADVENZYMES live share price for real-time trading data and today's change.
Index Memberships
Advanced Enzyme Technologies Limited is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY MICROCAP 250
NIFTYMICROCAP250
|
$142.42 Billion | 0.23% | #136 of 250 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.10 Trillion | 0.01% | #516 of 750 |
Weight: Advanced Enzyme Technologies Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Advanced Enzyme Technologies Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Advanced Enzyme Technologies Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore ADVENZYMES net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.04x
Advanced Enzyme Technologies Limited's market cap is 0.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.19x
Advanced Enzyme Technologies Limited's market cap is 0.19 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $317.20 Million | $3.30 Billion | $906.49 Million | 0.10x | 0.35x |
| 2018 | $202.52 Million | $3.88 Billion | $900.55 Million | 0.05x | 0.22x |
| 2019 | $190.40 Million | $4.18 Billion | $1.11 Billion | 0.05x | 0.17x |
| 2020 | $386.48 Million | $4.42 Billion | $1.29 Billion | 0.09x | 0.30x |
| 2021 | $377.40 Million | $5.00 Billion | $1.46 Billion | 0.08x | 0.26x |
| 2022 | $326.18 Million | $5.29 Billion | $1.20 Billion | 0.06x | 0.27x |
| 2023 | $443.70 Million | $5.41 Billion | $1.06 Billion | 0.08x | 0.42x |
| 2024 | $417.37 Million | $6.23 Billion | $1.33 Billion | 0.07x | 0.31x |
| 2025 | $362.13 Million | $6.37 Billion | $1.31 Billion | 0.06x | 0.28x |
| 2026 | $328.59 Million | $7.46 Billion | $1.69 Billion | 0.04x | 0.19x |
Competitor Companies of ADVENZYMES by Market Capitalization
Companies near Advanced Enzyme Technologies Limited in the global market cap rankings as of November 4, 2026. Also see Advanced Enzyme Technologies Limited assets under control for a full breakdown of the balance sheet.
Key companies related to Advanced Enzyme Technologies Limited by market ranking:
- Linde plc Ordinary Shares (NASDAQ:LIN): Ranked #95 globally with a market cap of $215.12 Billion USD.
- AIR LIQUIDE ADR 1/5/EO 11 (F:AILA): Ranked #242 globally with a market cap of $103.86 Billion USD ( €88.84 Billion EUR).
- Air Liquide SA (PA:AI): Ranked #253 globally with a market cap of $101.06 Billion USD ( €86.44 Billion EUR).
- Sherwin-Williams Co (NYSE:SHW): Ranked #319 globally with a market cap of $84.50 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #95 | Linde plc Ordinary Shares | NASDAQ:LIN | $215.12 Billion | $511.55 |
| #242 | AIR LIQUIDE ADR 1/5/EO 11 | F:AILA | $103.86 Billion | €36.60 |
| #253 | Air Liquide SA | PA:AI | $101.06 Billion | €182.56 |
| #319 | Sherwin-Williams Co | NYSE:SHW | $84.50 Billion | $340.87 |
Market Capitalization of Advanced Enzyme Technologies Limited (2016–2026)
Market capitalization of Advanced Enzyme Technologies Limited from 2016 to today. Between 2016 and today, Advanced Enzyme Technologies Limited's market cap moved from $452.81 Million to $ 328.59 Million, with a yearly change of 1.97%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs328.59 Million | -9.26% |
| 2025 | Rs362.13 Million | -13.23% |
| 2024 | Rs417.37 Million | -5.93% |
| 2023 | Rs443.70 Million | +36.03% |
| 2022 | Rs326.18 Million | -13.57% |
| 2021 | Rs377.40 Million | -2.35% |
| 2020 | Rs386.48 Million | +102.98% |
| 2019 | Rs190.40 Million | -5.99% |
| 2018 | Rs202.52 Million | -36.15% |
| 2017 | Rs317.20 Million | -29.95% |
| 2016 | Rs452.81 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Advanced Enzyme Technologies Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $328.59 Million USD |
| MoneyControl | $328.59 Million USD |
| MarketWatch | $328.59 Million USD |
| marketcap.company | $328.59 Million USD |
| Reuters | $328.59 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers serratiopeptidase, fungal lactase, peptizyme SP, nattokinase, fungal lipase, alpha galactosidase, saccharomyces boulardii, hemicellulose, papain, bromelain… Read more